Stocktoria
SI-BONE, Inc. SIBN
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2018-10-17
SI-BONE, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $200.9M | $167.2M | $138.9M | $106.4M | $90.2M |
| Gross profit | $159.9M | $132.1M | $109.4M | $90.7M | $79.7M |
| R&D expense | $17.4M | $16.6M | $15.0M | $13.6M | $12.4M |
| Operating income | -$22.3M | -$35.2M | -$46.9M | -$59.6M | -$51.7M |
| Interest expense | — | — | $3.5M | $2.8M | $5.4M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$18.9M | -$30.9M | -$43.3M | -$61.3M | -$56.6M |
| EPS (diluted) | $-0.44 | $-0.75 | $-1.13 | $-1.79 | $-1.71 |
| Operating cash flow | -$675,000 | -$12.4M | -$18.7M | -$41.7M | -$39.5M |
| Free cash flow | -$9.1M | -$22.9M | -$26.5M | -$51.2M | -$45.9M |
| Cash & equivalents | $42.2M | $34.9M | $33.3M | $20.7M | $63.4M |
| Inventory | $33.9M | $27.1M | $20.2M | $17.3M | $11.5M |
| Total assets | $238.6M | $230.4M | $230.4M | $157.6M | $190.5M |
| Total liabilities | $61.0M | $63.5M | $61.0M | $59.2M | $56.1M |
| Shareholders' equity | $177.5M | $167.0M | $169.4M | $98.3M | $134.4M |
Source: SEC EDGAR filings · CIK 0001459839 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.